Dimerix Limited reported earnings results for the full year ended June 30, 2023. For the full year, the company reported net loss was AUD 13.8 million compared to AUD 10.49 million a year ago. Basic loss per share from continuing operations was AUD 0.0424 compared to AUD 0.0356 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.325 AUD | -1.52% | -7.14% | +58.54% |
01/05 | Dimerix Secures Pediatric Plan Approval in the UK for Kidney Disease Medication | MT |
22/04 | Dimerix Posts AU$35.2 Million Cash, AU$3.3 Million Operating Cash Outflows for March Quarter | MT |
1st Jan change | Capi. | |
---|---|---|
+58.54% | 120M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+46.40% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- DXB Stock
- News Dimerix Limited
- Dimerix Limited Reports Earnings Results for the Full Year Ended June 30, 2023